Cited by 439Tryptophan and brain disordersStress Responses and CortisolNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 48 of the 51 references it cites were found in a registry or an index.

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6

Zalcman, Steve, Green-Johnson, Julia M., Murray, Linda, Nance, Dwight M., Dyck, Dennis, Anisman, Hymie, Greenberg, Arnold H.·1994·Brain Research

DOI 10.1016/0006-8993(94)90006-x

Open this paper in CoChat — free account

Abstract

Cytokine-specific alterations of monoamine activity were evident in the hypothalamus, hippocampus and prefrontal cortex 2 h following peripheral administration of recombinant interleukin (IL)-1 beta, IL-2 and IL-6 (200 ng, i.p.) in male, BALB/c mice. IL-1 induced the broadest range of neurochemical changes, affecting central norepinephrine (NE), serotonin (5-HT) and dopamine (DA) activity. In particular, IL-1 enhanced NE turnover in the hypothalamus and hippocampus, 5-HT turnover in the hippocampus and prefrontal cortex (owing to increased utilization and reduced content of the transmitters in these brain regions), and enhanced DA utilization in the prefrontal cortex. IL-6 increased 5-HT and DA activity in the hippocampus and prefrontal cortex in a manner similar to IL-1, but failed to affect central NE activity. Moreover, IL-2 increased hypothalamic NE turnover (reflecting a profound increase in NE utilization) and enhanced DA turnover in the prefrontal cortex, but did not influence central 5-HT activity. Hence, these cytokines differentially altered neurochemical activity in brain regions that mediate neuroimmune interactions and that are influenced by physical and psychological stressors. In addition to the neurochemical changes, plasma corticosterone concentrations were profoundly enhanced in IL-1-treated animals, but not significantly altered by IL-2 or IL-6 treatment. The IL-1-induced corticosterone elevations did not significantly correlate with alterations of hypothalamic NE activity.

Integrity signals

Registry

Crossref · 10.1016/0006-8993(94)90006-x

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151
Release of Multiple Hormones by a Direct Action of Interleukin-1 on Pituitary Cells
Bernton, E. W., Beach, J. E., Holaday, J. W., Smallridge, R. C., & Fein, H. G. (1987) · Science · doi:10.1126/science.2821620 · Cited by 671
The immune system as a sensory organ.
Blalock, J. E. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1067 · Cited by 551
Catecholaminergic Modulation of Corticotropin-Releasing Factor and Adrenocorticotropin Secretion
Plotsky, P. M., Cunningham, E. T., & Widmaier, E. P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-4-437 · Cited by 530
Immunoregulation mediated by the sympathetic nervous system
Besedovsky, H. O., del Rey, A., Sorkin, E., Prada, M. D., & Keller, H. H. (1979) · Cellular Immunology · doi:10.1016/0008-8749(79)90129-1 · Cited by 488
The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells
Denicoff, K. D., RUBINOW, D. R., PAPA, M. Z., SIMPSON, C., SEIPP, C. A., LOTZE, M. T., Chang, A. E., ROSENSTEIN, D., & Rosenberg, S. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-293 · Cited by 456
The Immune Response Evokes Changes in Brain Noradrenergic Neurons
Besedovsky, H. O., del Rey, A., Sorkin, E., Prada, M. D., Burri, R., & Honegger, C. G. (1983) · Science · doi:10.1126/science.6867729 · Cited by 445
Stress and the Mesocorticolimbic Dopamine Systemsa
ROTH, R. H., TAM, S., IDA, Y., YANG, J., & DEUTCH, A. Y. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb42102.x · Cited by 342

Show all 51 references

Research works printed but not linked: 3

Saphier, 1993, Central nervous system effects of α-interferon, Res. Persp. Psychoneuroimmunol., IV, A
Zalcman, 1993, IL-2-induced potentiation of immune, function is mediated by the sympathetic nervous system, Soc. Neurosci. Abstr., 19, 945
Zalcman, 1991, Alterations of central catecholamines associated with primary and secondary immunological challenge, Soc. Neurosci. Abstr., 17, 1202

Sorted by citations

Items 101–200 of 439

Cytokine dysregulation in the post-Q-fever fatigue syndrome
Penttila, I. (1998) · QJM · doi:10.1093/qjmed/91.8.549 · Cited by 104
Inflammation: a mechanism of depression?
Han, Q.-Q., & Yu, J. M. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1439-3 · Cited by 107
Mycoplasma pneumoniae infection and Tourette's syndrome
Müller, N., Riedel, M. J., Blendinger, C., Oberle, K., Jacobs, E., & Abele‐Horn, M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.009 · Cited by 100
Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms
Lieshout, R. J. V., & Voruganti, L. P. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0837 · Cited by 100
Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia
Ben‐Azu, B., Aderibigbe, A. O., Ajayi, A. M., Eneni, A.-E. O., Omogbiya, I. A., Owoeye, O., Umukoro, S., & Iwalewa, E. O. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.052 · Cited by 97
Reduced Preference for Sucrose in Autoimmune Mice
Šakić, B., Szechtman, H., Braciak, T. A., Richards, C. D., Gauldie, J., & Denburg, J. A. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00107-x · Cited by 96
Interleukin 6 and cognitive dysfunction
Trapero, I., & Cauli, O. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9551-2 · Cited by 98
Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: Involvement of the cyclo-oxygenase pathway
Linthorst, A. C. E., Flachskamm, C., Holsboer, F., & Reul, J. M. H. M. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00604-4 · Cited by 94
Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation
Anisman, H., Kokkinidis, L., & Merali, Z. (1996) · Brain Research · doi:10.1016/0006-8993(96)00460-x · Cited by 94
Self-citation
Intraperitoneal Administration of Bacterial Endotoxin Enhances Noradrenergic Neurotransmission in the Rat Preoptic Area: Relationship with Body Temperature and Hypothalamic‐Pituitary‐Adrenocortical Axis Activity
Linthorst, A. C. E., Flachskamm, C., Holsboer, F., & Reul, J. M. H. M. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01040.x · Cited by 93
Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis
Chang, J. P., Su, K., Mondelli, V., & Pariante, C. M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01550-0 · Cited by 99
Cellular and Humoral Immune System in Schizophrenia: A Conceptual Re-Evaluation
Müller, N., Riedel, M. J., Ackenheil, M., & Schwarz, M. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150588 · Cited by 91
Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
Borovčanin, M., Jovanović, I., Radosavljevic, G. D., Pantic, J. M., Janicijevic, S. M., Arsenijević, N., & Lukić, M. L. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00221 · Cited by 92
Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis
Misiak, B., Wójta-Kempa, M., Samochowiec, J., Schiweck, C., Aichholzer, M., Reif, A., Samochowiec, A., & Stańczykiewicz, B. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110581 · Cited by 93
Infectobesity: Obesity of Infectious Origin
Pasarica, M., & Dhurandhar, N. V. (2007) · Advances in food and nutrition research · doi:10.1016/s1043-4526(06)52002-9 · Cited by 88
Brain Neurotransmission during Peripheral Inflammationa
Linthorst, A. C. E., & Reul, J. M. H. M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09558.x · Cited by 88
Association of elevated cytokines with childhood adversity in a sample of healthy adults
Hartwell, K. J., Moran-Santa Maria, M. M., Twal, W. O., Shaftman, S., DeSantis, S. M., McRae-Clark, A. L., & Brady, K. T. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.01.008 · Cited by 87
Evidence for an Immune Role on Cognition in Schizophrenia: A Systematic Review
Ribeiro-Santos, R., Teixeira, A. L., & Salgado, J. V. (2014) · Current Neuropharmacology · doi:10.2174/1570159x1203140511160832 · Cited by 86
The chemokine stromal cell‐derived factor‐1/CXCL12 activates the nigrostriatal dopamine system
Skrzydelski, D., Guyon, A., Daugé, V., Rovère, C., Apartis, E., Kitabgi, P., Nahon, J., Rostène, W. H., & Parsadaniantz, S. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04639.x · Cited by 85
Cracking the riddle of cancer anorexia
Laviano, A., Meguid, M. M., Yang, Z., Gleason, J. R., Cangiano, C., & Fanelli, F. R. (1996) · Nutrition · doi:10.1016/s0899-9007(96)00164-5 · Cited by 85
Polycystic ovary syndrome and circulating inflammatory markers
Zangeneh, F. Z., Naghizadeh, M., & Masoumi, M. (2017) · International Journal of Reproductive BioMedicine · doi:10.29252/ijrm.15.6.375 · Cited by 77
Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration
Hayley, S. P. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4476 · Cited by 81
Anti-Yo Antibodies in Children With ADHD: First Results About Serum Cytokines
Donfrancesco, R., Nativio, P., Benedetto, A. D., Villa, M. P., Andriola, E., Melegari, M. G., Cipriano, E., & Trani, M. D. (2016) · Journal of Attention Disorders · doi:10.1177/1087054716643387 · Cited by 82
Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression
Phillips, C., & Fahimi, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00498 · Cited by 89
Immunological Aetiology of Major Psychiatric Disorders
Sperner‐Unterweger, B. (2005) · Drugs · doi:10.2165/00003495-200565110-00004 · Cited by 83
Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics
Zhang, X. Y., Zhou, D. F., Qi, L. Y., Chen, S., Cao, L. Y., Chen, D. C., Xiu, M. H., Wang, F., Wu, G. Y., Lü, L., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1447-6 · Cited by 81
The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1β
Wang, J., & Dunn, A. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01091-9 · Cited by 81
Sustained Elevation of Serum Interleukin-6 and Relative Insensitivity to Hydrocortisone Differentiates Posttraumatic Stress Disorder with and Without Depression
Gill, J., Luckenbaugh, D., Charney, D., & Vythilingam, M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.033 · Cited by 80
Hippocampal damage in mouse and human forms of systemic autoimmune disease
Ballok, D. A., Woulfe, J., Sur, M., Cyr, M., & Šakić, B. (2004) · Hippocampus · doi:10.1002/hipo.10205 · Cited by 79
Olfactory Bulbectomy Provokes a Suppression of Interleukin-1β and Tumour Necrosis Factor-α Production in Response to an in vivo Challenge with Lipopolysaccharide: Effect of Chronic Desipramine Treatment
Connor, T. J., Harkin, A., Kelly, J. P., & Leonard, B. E. (1999) · NeuroImmunoModulation · doi:10.1159/000026417 · Cited by 80
The role of tumor necrosis factor-α in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity
Holden, R. J., & Pakula, I. S. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90153-x · Cited by 79
Immunological Dysfunction in Tourette Syndrome and Related Disorders
Hsu, C., Wong, L., & Lee, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020853 · Cited by 79
Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation
Anisman, H., Kokkinidis, L., Borowski, T. B., & Merali, Z. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01114-1 · Cited by 74
Self-citation
Anti-inflammatory signaling in schizophrenia
Meyer, U. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.014 · Cited by 72
Molecular Mechanisms of Actions of Interleukin-6 on the Brain, with Special Reference to Serotonin and the Hypothalamo-Pituitary-Adrenocortical Axis
Barkhudaryan, N., & Dunn, A. J. (1999) · Neurochemical Research · doi:10.1023/a:1020720722209 · Cited by 73
Chlorpromazine and loxapine reduce interleukin-1β and interleukin-2 release by rat mixed glial and microglial cell cultures
Łabuzek, K., Kowalski, J., Gabryel, B., & Herman, Z. S. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.04.002 · Cited by 70
T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment
Maino, K., Gruber, R., Riedel, M. J., Seitz, N., Schwarz, M., & Müller, N. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.06.004 · Cited by 70
Prenatal maternal immune disruption and sex-dependent risk for psychoses
Goldstein, J. M., Cherkerzian, S., Seidman, L. J., Donatelli, J.-A. L., Remington, A., Tsuang, M. T., Hornig, M., & Buka, S. L. (2014) · Psychological Medicine · doi:10.1017/s0033291714000683 · Cited by 71
Relationship between Interleukin-6 Gene Polymorphism and Hippocampal Volume in Antipsychotic-Naïve Schizophrenia: Evidence for Differential Susceptibility?
Kalmady, S. V., Venkatasubramanian, G., Shivakumar, V., Gautham, S., Subramaniam, A., Jose, D. A., Maitra, A., Ravi, V., & Gangadhar, B. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096021 · Cited by 69
Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice
Swiergiel, A. H., & Dunn, A. J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.024 · Cited by 69
Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology
Miller, B. J., & Goldsmith, D. R. (2019) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2019.100006 · Cited by 72
Neuroimmune–endocrine crosstalk in schizophrenia and mood disorders
Müller, N., & Schwarz, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.1017 · Cited by 70
Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum
Zhang, J., Terreni, L., Simoni, M. G. D., & Dunn, A. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00099-1 · Cited by 67
Perinatal supplementation with thymoquinone improves diabetic complications and T cell immune responses in rat offspring
Badr, G., Alwasel, S. H., Ebaid, H., Mohany, M., & Alhazza, I. M. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.01.002 · Cited by 64
Plasma Interleukin-1β and Tumor Necrosis Factor Concentrations in Obsessive–Compulsive Disorders
Brambilla, F., Perna, G., Bellodi, L., Arancio, C., Bertani, A., Perini, G., Carraro, C., & Gava, F. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00495-7 · Cited by 65
Serum tumour necrosis factor-alpha is associated with poor health-related quality of life and depressive symptoms in patients with systemic lupus erythematosus
Mak, A., Tang, C. S., & Ho, R. (2013) · Lupus · doi:10.1177/0961203312471872 · Cited by 65
Evaluation of the neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as inflammatory markers in children with attention‐deficit hyperactivity disorder
Avcıl, S. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12659 · Cited by 68
Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats
Zalcman, S., Savina, I., & Wise, R. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02063-6 · Cited by 64
Self-citation
Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists
Zalcman, S. S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02740-3 · Cited by 64
Self-citation
Neuroimmune Impacts of Early-Life Stress on Development and Psychopathology
Brenhouse, H. C., Danese, A., & Grassi‐Oliveira, R. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_53 · Cited by 65
ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats
Kozłowska, A., Wojtacha, P., Równiak, M., Kolenkiewicz, M., & Huang, A. C. W. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5180-0 · Cited by 64
Relation between depression and circulating immune products in patients with advanced colorectal cancer
Allen-Mersh, T. G., Glover, C., Fordy, C., Henderson, D. C., & Davies, M. (1998) · Journal of the Royal Society of Medicine · doi:10.1177/014107689809100803 · Cited by 63
Potentiating role of interleukin-1β (IL-1β) and IL-1β type 1 receptors in the medial hypothalamus in defensive rage behavior in the cat
Hassanain, M., Bhatt, S., Zalcman, S. S., & Siegel, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.086 · Cited by 63
Self-citation
Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment
Debnath, M. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9626-9 · Cited by 60
Central Monoamine Activity following Acute and Repeated Systemic Interleukin-2 Administration
Lacosta, S., Merali, Z., & Anisman, H. (2000) · NeuroImmunoModulation · doi:10.1159/000026457 · Cited by 62
Self-citation
Neural Mechanisms of Cancer Cachexia
Olson, B. G., Diba, P., Korzun, T., & Marks, D. L. (2021) · Cancers · doi:10.3390/cancers13163990 · Cited by 62
Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development
Möller, M., Swanepoel, T., & Harvey, B. H. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5003368 · Cited by 60
Neurotoxic consequences of central long-term administration of interleukin-2 in rats
Hanisch, U., Neuhaus, J., Rowe, W. B., van Rossum, D., Möller, T., Kettenmann, H., & Quirion, R. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00040-7 · Cited by 59
Taurine, an essential β-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative/nitrergic imbalances, and suppression of COX-2/iNOS immunoreactions in mice
Ben‐Azu, B., Adebayo, O. G., Jarikre, T. A., Oyovwi, M. O., Edje, K. E., Omogbiya, I. A., Eduviere, A. T., Moke, E. G., Chijioke, B. S., Odili, O. S., et al. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01075-5 · Cited by 64
Prenatal maternal immune activation and brain development with relevance to psychiatric disorders
Scola, G., & Duong, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.033 · Cited by 61
Presence of a reduced opioid response in interleukin‐6 knock out mice
Bianchi, M., Maggi, R., Pimpinelli, F., Rubino, T., Parolaro, D., Poli, V., Ciliberto, G., Panerai, A. E., & Sacerdote, P. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00563.x · Cited by 58
Long-term exposure to ceftriaxone sodium induces alteration of gut microbiota accompanied by abnormal behaviors in mice
Zhao, Z., Wang, B., Mu, L., Wang, H., Luo, J., Yang, Y., Yang, H., Li, M., Zhou, L., & Tao, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00258 · Cited by 57
Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients
Müller, N., Dobmeier, P., Empl, M., Riedel, M. J., Schwarz, M., & Ackenheil, M. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)84789-x · Cited by 57
Immune-mediated animal models of Tourette syndrome
Hornig, M., & Lipkin, W. I. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.007 · Cited by 56
Immunity and schizophrenia: Autoimmunity, cytokines, and immune responses
Gaughran, F. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)52013-4 · Cited by 56
Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: Effects of antipsychotic drugs
Crespo‐Facorro, B., Carrasco-Marı́n, E., Pérez‐Iglesias, R., Pelayo‐Terán, J. M., Fernández-Prieto, L., Leyva‐Cobián, F., & Vázquez‐Barquero, J. L. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2006.08.005 · Cited by 55
Role of IL-1β and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat
Bhatt, S., Bhatt, R., Zalcman, S. S., & Siegel, A. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.07.011 · Cited by 55
Self-citation
Immune system: A possible nexus between cannabinoids and psychosis
Suárez‐Pinilla, P., López-Gil, J., & Crespo‐Facorro, B. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.01.018 · Cited by 56
Interleukin-1β in the hypothalamus potentiates feline defensive rage: role of SEROTONIN-2 receptors
Hassanain, M., Zalcman, S. S., Bhatt, S., & Siegel, A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00264-1 · Cited by 55
Self-citation
T-Lymphocyte Activation Increases Hypothalamic and Amygdaloid Expression of CRH mRNA and Emotional Reactivity to Novelty
Kusnecov, A. W., Liang, R., & Shurin, G. V. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04533.1999 · Cited by 54
Neurochemistry of Brain Neuroendocrine Immune System: Signal Molecules
Galoyan, A. A. (2000) · Neurochemical Research · doi:10.1023/a:1007656431612 · Cited by 55
Cytokine-Neurotransmitter Interactions in the Brain
Simoni, M. G. D., & Imeri, L. (1998) · Neurosignals · doi:10.1159/000014526 · Cited by 55
Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity
Zalcman, S. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02090-x · Cited by 55
Self-citation
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers
Rapaport, M. H., McAllister, C. G., Pickar, D., Tamarkin, L., Kirch, D. G., & Paul, S. M. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00008-x · Cited by 54
Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients
Singh, B., Bera, N. K., Nayak, C. R., & Chaudhuri, T. K. (2009) · Cytokine · doi:10.1016/j.cyto.2009.05.005 · Cited by 52
Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia
Srinivas, L., Vellichirammal, N. N., Alex, A. M., Nair, C. M., Nair, I. V., & Banerjee, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0569-8 · Cited by 52
Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs
Araújo, T. D. S., Filho, A. J. M. C., Monte, A. S., Queiroz, A. I. D. G., Cordeiro, R. C., Machado, M. D. J. S., Lima, R. D. F., de Lucena, D. F., Maes, M. H. J., & Macêdo, D. S. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.017 · Cited by 55
IL1 Beta Impairs Relational but Not Procedural Rodent Learning in a Water Maze Task
Gibertini, M. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0407-4_27 · Cited by 52
Early-Life Adversity, Systemic Inflammation and Comorbid Physical and Psychiatric Illnesses of Adult Life
Nettis, M. A., Pariante, C. M., & Mondelli, V. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_89 · Cited by 53
Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients
Sirota, P., Meiman, M. E., Hershko, R., & Bessler, H. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.012 · Cited by 51
Effects of interferon-?, interleukin-1?, and tumor necrosis factor-? on the serotonin metabolism in the nucleus raphe dorsalis of the rat
Clement, H. W., Buschmann, J., Rex, S., Grote, C., Opper, C., Gemsa, D., & Wesemann, W. (1997) · Journal of Neural Transmission · doi:10.1007/bf01273312 · Cited by 50
Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system.
Banks, W., Niehoff, M., & Zalcman, S. (2004) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2003.09.013 · Cited by 54
Self-citation
The Neuroimmunological Basis of Behavior and Mental Disorders
Siegel, A., & Zalcman, S. S. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8 · Cited by 51
Self-citation
The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, on immune function
Song, C., & Leonard, B. E. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100103 · Cited by 50
Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
Wang, Y., Meng, W., Liu, Z., An, Q., & Hu, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1046692 · Cited by 51
Cytokines, stressors, and clinical depression: Augmented adaptation responses underlie depression pathogenesis
Simmons, D. A., & Broderick, P. A. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.009 · Cited by 51
In Vitro Cytokine Secretion in Individuals with Schizophrenia: Results, Confounding Factors, and Implications for Further Research
Hinze‐Selch, D., & Pollmächer, T. (2001) · Brain Behavior and Immunity · doi:10.1006/brbi.2001.0645 · Cited by 49
Multiple cerebral lesions complicating therapy with interleukin-2
Karp, B. P., Yang, J. C., Khorsand, M., Wood, R., & Merigan, T. C. (1996) · Neurology · doi:10.1212/wnl.47.2.417 · Cited by 49
Inflammation-related transcripts define “high” and “low” subgroups of individuals with schizophrenia and bipolar disorder in the midbrain
Zhu, Y., Owens, S. J., Murphy, C. E., Ajulu, K., Rothmond, D. A., Purves-Tyson, T. D., Middleton, F. A., Webster, M. J., & Weickert, C. S. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.012 · Cited by 49
Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia
Frydecka, D., Misiak, B., Beszłej, J. A., Karabon, L., Pawlak, E., Tomkiewicz, A., Partyka, A., Jonkisz, A., & Kiejna, A. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2662-8 · Cited by 47
Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells
Alboni, S., Montanari, C., Benatti, C., Sánchez-Alavez, M., Rigillo, G., Blom, J. M. C., Brunello, N., Conti, B., Pariante, C. M., & Tascedda, F. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.02.015 · Cited by 46
Potentiating role of interleukin 2 (IL-2) receptors in the midbrain periaqueductal gray (PAG) upon defensive rage behavior in the cat: Role of neurokinin NK1 receptors
Bhatt, S., & Siegel, A. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.09.011 · Cited by 46
New aspects of immunotherapy of leptomeningeal metastasis
Herrlinger, U., Weller, M., & Schabet, M. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005948722912 · Cited by 46
COX-2 Inhibitors as Adjunctive Therapy in Schizophrenia
Riedel, M. J., Strassnig, M., Schwarz, M., & ller, N. M. ⁄. (2005) · CNS Drugs · doi:10.2165/00023210-200519100-00001 · Cited by 45
Cyclosporine A Affects Open Field Behavior in DA Rats
von Hörsten, S., Exton, M. S., Vöge, J., Schult, M., Nagel, E., Schmidt, R., Westermann, J., & Schedlowski, M. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00467-x · Cited by 45
Mechanisms by which cytokines signal the brain
Dunn, A. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)52005-5 · Cited by 44
Chronic Fatigue Syndrome: An Immunological Perspective
Vollmer-Conna, U. S., Lloyd, A. R., Hickie, I. B., & Wakefield, D. (1998) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679809068326 · Cited by 45
Chronic Systemic Inflammation Is Associated With Symptoms of Late-Life Depression: The ARIC Study
Sonsin-Diaz, N., Gottesman, R. F., Fracica, E., Walston, J., Windham, B. G., Knopman, D. S., & Walker, K. A. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.05.011 · Cited by 44
Between Dysbiosis, Maternal Immune Activation and Autism: Is There a Common Pathway?
Suprunowicz, M., Tomaszek, N., Urbaniak, A., Zackiewicz, K., Modzelewski, S., & Waszkiewicz, N. (2024) · Nutrients · doi:10.3390/nu16040549 · Cited by 44
Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials
Marini, S., Berardis, D. D., Vellante, F., Santacroce, R., Orsolini, L., Valchera, A., Girinelli, G., Carano, A., Fornaro, M., Gambi, F., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/3476240 · Cited by 48

Authors: Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., & Greenberg, A. H.
Affiliations: University of Manitoba (CA)
Carleton University (CA)
Corresponding author: Greenberg, Arnold H.
ORCID: Green-Johnson, Julia M.
Murray, Linda
Venue: Brain Research
Publisher: Elsevier BV
Published: 1994-04
Volume: 643
Issue: 1-2
Pages: 40-49
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/0006-8993(94)90006-x
OpenAlex: W2082698695
Cited by: 439
References: 51
Citations by year: 2026: 2 · 2025: 3 · 2024: 6 · 2023: 11 · 2022: 13 · 2021: 12 · 2020: 11 · 2019: 17 · 2018: 13 · 2017: 14 · 2016: 12 · 2015: 7 · 2014: 19 · 2013: 14 · 2012: 18
FWCI: 7.23
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (R01MH043778, MH-43778-04A2)
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: IL-1β, interleukin-2, interleukin-6, cytokines, monoamines, norepinephrine turnover, serotonin turnover, dopamine turnover, hypothalamus, hippocampus, prefrontal cortex, neuroimmune interactions, corticosterone, stress response
MeSH terms: Animals, Brain, Chromatography, High Pressure Liquid, Corticosterone, Dopamine, Hippocampus, Humans, Hydroxyindoleacetic Acid, Hypothalamus, Interleukin-1, Interleukin-2, Male, Methoxyhydroxyphenylglycol, Mice, Inbred BALB C, Norepinephrine, Recombinant Proteins, Reference Values, 3,4-Dihydroxyphenylacetic Acid, Biogenic Monoamines, Interleukin-6, Prefrontal Cortex, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks